{"DataElement":{"publicId":"4537853","version":"1","preferredName":"EGFR Gene Assessment Mutation Abnormality Code","preferredDefinition":"The specific EGFR mutation identified.","longName":"3139428v1.0:4537785v1.0","context":"SWOG","contextVersion":"1","DataElementConcept":{"publicId":"3139428","version":"1","preferredName":"Mutation Abnormality EGFR Gene Status Assessment","preferredDefinition":"Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer._A condition or state at a particular time._The EGFR gene at chromosome 7p12.3-p12.1 encodes the EGFreceptor, a cell surface transmembrane protein tyrosine kinase involved in regulation of cell growth and differentiation. The gene is not expressed in mitotically quiescent cells, except in the stomach where it controls the synthesis and release of digestive enzymes and gastric acid. EGFR tyrosine kinase activity is required for internalization or degradation of EGF-EGFR receptor complexes. EGFR signaling involves small RHO GTPases and EGFR trafficking involves small RAB GTPases._The final result of a determination of the value, significance, or extent of.","longName":"3140537v1.0:2465182v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"3140537","version":"1","preferredName":"Mutation Abnormality Status EGFR Gene","preferredDefinition":"A general term referring to single or multiple alterations in the genetic material of an organism that ranges from a single base change in a gene to the loss or addition of complete chromosomes. A mutation abnormality may be heritable or occur somatically.:A condition or state at a particular time.:The EGFR gene at chromosome 7p12.3-p12.1 encodes the EGFreceptor, a cell surface transmembrane protein tyrosine kinase involved in regulation of cell growth and differentiation. The gene is not expressed in mitotically quiescent cells, except in the stomach where it controls the synthesis and release of digestive enzymes and gastric acid. EGFR tyrosine kinase activity is required for internalization or degradation of EGF-EGFR receptor complexes. EGFR signaling involves small RHO GTPases and EGFR trafficking involves small RAB GTPases.","longName":"C45576:C25688:C17757","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mutation Abnormality","conceptCode":"C45576","definition":"Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"EGFR Gene","conceptCode":"C17757","definition":"This gene is involved in the epidermal growth factor signal transduction pathway.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"90CB2498-1311-F587-E040-BB89AD4345F0","latestVersionIndicator":"Yes","beginDate":"2010-09-21","endDate":null,"createdBy":"WHITES","dateCreated":"2010-09-21","modifiedBy":"ONEDATA","dateModified":"2010-09-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2465182","version":"1","preferredName":"Assessed","preferredDefinition":"Having determined the value, significance, or extent of.","longName":"C25217","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Assessment","conceptCode":"C25217","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F836E72-26FF-3EB2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-22","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-03-22","modifiedBy":"ONEDATA","dateModified":"2006-03-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Application","id":"90B8A833-01A1-5148-E040-BB89AD4346DE","latestVersionIndicator":"Yes","beginDate":"2010-09-20","endDate":null,"createdBy":"WHITES","dateCreated":"2010-09-20","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Curated for The Cancer Genome Atlas (TCGA) by request of S.Ratliff. 09/2010 sw.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"4537785","version":"1","preferredName":"EGFR Gene Mutation Abnormality Code","preferredDefinition":"The EGFR gene at chromosome 7p12.3-p12.1 encodes the EGFreceptor, a cell surface transmembrane protein tyrosine kinase involved in regulation of cell growth and differentiation. The gene is not expressed in mitotically quiescent cells, except in the stomach where it controls the synthesis and release of digestive enzymes and gastric acid. EGFR tyrosine kinase activity is required for internalization or degradation of EGF-EGFR receptor complexes. EGFR signaling involves small RHO GTPases and EGFR trafficking involves small RAB GTPases._A general term referring to single or multiple alterations in the genetic material of an organism that ranges from a single base change in a gene to the loss or addition of complete chromosomes. A mutation abnormality may be heritable or occur somatically._Type; a subdivision of a particular kind of thing._A system of numbered categories for representation of data.","longName":"4537785v1.0","context":"SWOG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"1","valueDescription":"Exon 19 deletion","ValueMeaning":{"publicId":"4537786","version":"1","preferredName":"Exon 19 deletion","longName":"4537786","preferredDefinition":"The sequences of a gene that are present in the final, mature, spliced messenger RNA molecule from that gene. A loss of any genetic material on a chromosome, ranging from loss of a single nucleotide, to loss of part or all of a gene, to loss of a visible portion of the chromosome involving multiple genes. Deletions often disrupt gene or protein function and cell function as a result.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"057B2642-AFAC-BAC5-E050-BB89AD4302EA","latestVersionIndicator":"Yes","beginDate":"2014-10-15","endDate":null,"createdBy":"NELSONA","dateCreated":"2014-10-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"057B2642-AFC5-BAC5-E050-BB89AD4302EA","beginDate":"2014-10-15","endDate":null,"createdBy":"NELSONA","dateCreated":"2014-10-15","modifiedBy":"ONEDATA","dateModified":"2014-10-15","deletedIndicator":"No"},{"value":"2","valueDescription":"L858R Mutation","ValueMeaning":{"publicId":"5333904","version":"1","preferredName":"L858R Mutation","longName":"5333904","preferredDefinition":"A change in the amino acid residue at position 858 in the epidermal growth factor receptor protein where leucine has been replaced by arginine.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"36849FB1-165C-1470-E050-BB89AD4365C0","latestVersionIndicator":"Yes","beginDate":"2016-06-30","endDate":null,"createdBy":"ANDERSONR","dateCreated":"2016-06-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"37250258-62F7-6EEA-E050-BB89AD430CDE","beginDate":"2016-07-08","endDate":null,"createdBy":"ANDERSONR","dateCreated":"2016-07-08","modifiedBy":"ONEDATA","dateModified":"2016-07-08","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"4537784","version":"1","preferredName":"EGFR Gene Mutation Abnormality Code","preferredDefinition":"This gene is involved in the epidermal growth factor signal transduction pathway.:Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.:A system of numbered categories for representation of data.","longName":"C17757:C45576:C25162","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EGFR Gene","conceptCode":"C17757","definition":"This gene is involved in the epidermal growth factor signal transduction pathway.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Mutation Abnormality","conceptCode":"C45576","definition":"Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"057B2642-AF86-BAC5-E050-BB89AD4302EA","latestVersionIndicator":"Yes","beginDate":"2014-10-15","endDate":null,"createdBy":"NELSONA","dateCreated":"2014-10-15","modifiedBy":"ONEDATA","dateModified":"2014-10-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"SWOG CRF:Southwest Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"057B2642-AF97-BAC5-E050-BB89AD4302EA","latestVersionIndicator":"Yes","beginDate":"2014-10-15","endDate":null,"createdBy":"NELSONA","dateCreated":"2014-10-15","modifiedBy":"ANDERSONR","dateModified":"2016-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"EGFR mutation type","type":"Preferred Question Text","description":"EGFR mutation type","url":null,"context":"SWOG"}],"origin":"SWOG CRF:Southwest Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"057B2642-B00A-BAC5-E050-BB89AD4302EA","latestVersionIndicator":"Yes","beginDate":"2014-10-15","endDate":null,"createdBy":"NELSONA","dateCreated":"2014-10-15","modifiedBy":"NELSONA","dateModified":"2014-10-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}